USPTO serial 87825579
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Darmstadt, DE
Darmstadt, DE
Darmstadt, DE
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
William C. Wright
William C. Wright EPSTEIN DRANGEL LLP60 EAST 42ND STREET, SUITE 2520NEW YORK, NY 10165United States| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Electronic databases in the fields of drug development and drug manufacturing, recorded on computer media; bioinformatics software for storing, indexing, searching, retrieving, and accessing information about biological data for use in retrosynthesis, optimization of organic chemistry reactions and synthesis, assessing synthetic accessibility of real and virtual molecules, and drug discovery, drug development, and drug manufacturing; chemoinformatics software for storing, indexing, searching, retrieving, and accessing information about chemical compounds and chemical data for use in retrosynthesis, optimization of organic chemistry reactions and synthesis, assessing synthetic accessibility of real and virtual molecules, drug discovery, drug development, and drug manufacturing; software for use in biological and chemical modelling, analysis and information management for use in retrosynthesis, optimization of organic chemistry reactions and synthesis, assessing synthetic accessibility of real and virtual molecules, drug discovery, drug development, and drug manufacturing; software for computer-aided molecular design, data processing and data analysis for use in retrosynthesis, optimization of organic chemistry reactions and synthesis, assessing synthetic accessibility of real and virtual molecules, drug discovery, drug development, and drug manufacturing; chemical data analysis software for use in retrosynthesis, optimization of organic chemistry reactions and synthesis, assessing synthetic accessibility of real and virtual molecules, drug discovery, drug development, and drug manufacturing; drug discovery information systems software used to solve problems in connection with chemical syntheses for use in the field of organic chemistry; none of the foregoing for use in connection with synthetic patients, simulated patients, synthetic electronic patient healthcare records, synthetic patient data and associated healthcare records, nor in the field of medical science and medical consultancy | ACTIVE | — |
| 038 | Providing access to databases for use in retrosynthesis, optimization of organic chemistry reactions and synthesis, assessing synthetic accessibility of real and virtual molecules, drug discovery, drug development, and drug manufacturing; none of the foregoing for use in connection with synthetic patients, simulated patients, synthetic electronic patient healthcare records, synthetic patient data and associated healthcare records, nor in the field of medical science and medical consultancy | ACTIVE | — |
| 042 | Biotechnology and pharmaceutical research relating to retrosynthesis, optimization of organic chemistry reactions and synthesis, assessing synthetic accessibility of real and virtual molecules, and drug development; professional consultancy in relation to drug development; scientific research and development for others; scientific research in the nature of analysis and preparation of data relating to retrosynthesis, optimization of organic chemistry reactions and synthesis, assessing synthetic accessibility of real and virtual molecules, drug discovery and drug development; provision of information in relation to drug discovery and drug development; provision of scientific information related to pharmacy; none of the foregoing for use in connection with synthetic patients, simulated patients, synthetic electronic patient healthcare records, synthetic patient data and associated healthcare records, nor in the field of medical science and medical consultancy | ACTIVE | — |
| 045 | Licensing of computer software used for retrosynthesis, optimization of organic chemistry reactions and synthesis, assessing synthetic accessibility of real and virtual molecules, drug discovery, drug development, and drug manufacturing; none of the foregoing for use in connection with synthetic patients, simulated patients, synthetic electronic patient healthcare records, synthetic patient data and associated healthcare records, nor in the field of medical science and medical consultancy | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 26, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Nov 26, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 24, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 24, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 4, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 15, 2024 | ERRR | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | — |
| Aug 13, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 13, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 13, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 13, 2024 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Apr 15, 2024 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Apr 15, 2024 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Apr 15, 2024 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Apr 12, 2024 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Oct 11, 2023 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Oct 11, 2023 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Mar 3, 2023 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Mar 2, 2023 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Feb 14, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 30, 2022 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Apr 28, 2022 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Apr 28, 2022 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Apr 28, 2022 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Feb 21, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 21, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 21, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 3, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 23, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 23, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 23, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 26, 2021 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Jun 23, 2020 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Jun 22, 2020 | ALIE | ASSIGNED TO LIE | — |
| Dec 20, 2019 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Jun 10, 2019 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jun 10, 2019 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jun 10, 2019 | CNSL | SUSPENSION LETTER WRITTEN | — |
| May 20, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 20, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 16, 2019 | ALIE | ASSIGNED TO LIE | — |
| May 9, 2019 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Mar 19, 2019 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Mar 19, 2019 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Mar 19, 2019 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Mar 12, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 11, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 11, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 8, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 8, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 8, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 2, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 2, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 2, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 4, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 4, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 4, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 27, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 14, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 12, 2018 | NWAP | NEW APPLICATION ENTERED | — |